Contract Services

Merck and Universal Agree on the large-scale production of a new pediatric medication.

Merck has entered into a contract manufacturing agreement with Universal Corporation Ltd., Nairobi, Kenya, for the large-scale production of a new pediatri...

 July 16, 2021 | News

Inotiv Acquires Genetic Toxicology Assets from Merck's BioReliance® portfolio

Robert Leasure, Jr., President and CEO of Inotiv, commented, “This transaction with MilliporeSigma adds genetic toxicology to our suite of internal c...

 July 14, 2021 | News

Atossa Therapeutics Receives Approval To Open Clinical Study of AT-H201 in Australia

Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signi...

 July 08, 2021 | News

Toxicology IND Preclinical Research Services by Altogen Labs CRO

Pharmacology and toxicology testing performed both in vitro and in vivo, ensuring safety and effectiveness that is of utmost importance for any novel medic...

 July 06, 2021 | News

Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs

Key Points GBM AGILE pivotal study of paxalisib is recruiting ahead of expectations, with almost 25 sites now open to the paxalisib arm. Paxalisib phas...

 July 01, 2021 | News

Aragen Announces Expansion of Discovery Research Agreement with Boehringer Ingelheim

This preferred partnership allows Boehringer Ingelheim, a leading research driven pharmaceutical company, to incorporate several design elements, synthesiz...

 June 30, 2021 | News

RedHill Biopharma's Opaganib Inhibits COVID-19 Variants in Preclinical Study

Opaganib's unique, orally-administered, host-targeted, dual antiviral and anti-inflammatory approach to combatting COVID-19 is also expected to maintain ef...

 June 29, 2021 | News

Samsung Biologics continues to leverage remote audits and regulatory inspections

Samsung Biologics' Live Virtual Tour (LVT) used in one of the earliest FDA full virtual assessments Recently hosted EMA for 6 PAIs simultaneously using ...

 June 24, 2021 | News

Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia

On June 21, local time, phase III clinical fieldwork of the Inactivated COVID-19 Vaccine (Vero cells) independently developed and manufactured by Shen...

 June 23, 2021 | News

BIO to Hold First-Ever Clinical Trial Diversity Summit

The Biotechnology Innovation Organization (BIO) will hold its first-ever BIO Clinical Trial Diversity Summit June 24-25, 2021 to focus on th...

 June 22, 2021 | News

Vibalogics to expand cGMP manufacturing capacity for viral vectors

The investment by the CDMO, which specializes in the production of oncolytic viruses, viral vector vaccines and viral vector gene therapy products includes...

 June 17, 2021 | News

Medidata to Offer Secure Platform for Decentralization of Clinical Trials

  The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end...

 June 16, 2021 | News

Novavax Announces Positive Data for COVID-19 Beta (B.1.351) Variant Strain Vaccine

Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine - Primates boosted with rS-B.1.351 vacc...

 June 12, 2021 | News

WuXi XDC and LCB Signed MOU for the Development and Manufacturing of Antibody-drug Conjugates

Under the partnership, LCB will have access to XDC' integrated services in mAb, linker, payload, analytical and formulation development as well as ADC drug...

 June 10, 2021 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close